Heterologous Priming-Boosting Immunization of Cattle with Mycobacterium tuberculosis 85A Induces Antigen-Specific T-Cell Responses

Infection and Immunity

Volumn 71, Issue 12, 2003, Pages 6906-6914

  Taracha, Evans L N ^a   Bishop, Richard ^a   Musoke, Antony J ^a   Hill, Adrian V S ^b,c   Gilbert, Sarah C ^b  

^a INTERNATIONAL LIVESTOCK RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN 85A; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; PLASMID DNA; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CATTLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ASSAY; FEMALE; FOWLPOX VIRUS; INOCULATION; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS;

ACYLTRANSFERASES; ANIMALS; ANTIGENS, BACTERIAL; CATTLE; CATTLE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FOWLPOX VIRUS; IMMUNIZATION; IMMUNIZATION, SECONDARY; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; PEPTIDES; PLASMIDS; RECOMBINANT PROTEINS; TUBERCULOSIS VACCINES; TUBERCULOSIS, BOVINE; VACCINES, DNA;

EID: 0345714746     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.12.6906-6914.2003     Document Type: Article

References (37)

1. Allen, T. M., T. U. Vogel, D. H. Fuller, B. R. Mothe, S. Steffen, J. E. Boyson, T. Shipley, J. Fuller, T. Hanke, A. Sette, J. D. Altman, B. Moss, A. J. McMichael, and D. I. Watkins. 2000. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. J. Immunol. 164:4968-4978.
2. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. I. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, M. A. Candido, N. L. Kozyr, P. L. Earl, J. M. Smith, H.-L. Ma, B. D. Grimm, M. L. Hulsey, H. M. McClure, J. M. McNicholl, B. Moss, and H. L. Robinson. 2002. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Vaccine 20:1949-1955.
3. Andersen, P., A. B. Andersen, A. L. Sorensen, and S. Nagai. 1995. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J. Immunol. 154:3359-3372.
4. Barnes, P. F., S. Lu, J. S. Abrams, E. Wang, M. Yamamura, and R. L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61:3482-3489.
5. Bos, J. D., and M. L. Kapsenberg. 1993. The skin immune system: progress in cutaneous biology. Immunol. Today 14:75-78.
6. Brandt, L., J. F. Cunha, A. W. Olsen, B. Chilima, P. Hirsch, R. Appelberg, and P. Andersen. 2002. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70:672-678.
7. Bruna-Romero, O., G. Gonzalez-Aseguinolaza, J. C. R. Hafalla, M. Tsuji, and R. S. Nussenzweig. 2001. Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen. Proc. Natl. Acad. Sci. USA 98:11491-11496.
8. Buddle, B. M., G. W. De Lisle, A. Pfeffer, and F. E. Aldwell. 1995. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 13:1123-1130.
9. Buddle, B. M. 2001. Vaccination of cattle against Mycobacterium bovis. Tuberculosis (Edinburgh) 81:125-132.
10. Chakrabarti, S., K. Brechling, et al. 1985. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
11. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect. Immun. 66:1527-1533.
12. Gilbert, S. C., J. Schneider, M. Plebanski, C. M. Hannan, T. J. Blanchard, G. L. Smith, and A. V. S. Hill. 1999. Ty virus-like particles, DNA vaccines and modified vaccinia virus Ankara; comparisons and combinations. Biol. Chem. 380:299-303.
13. Goddeeris, B. M., and W. I. Morrison. 1998. Techniques for the generation, cloning and characterisation of bovine cytotoxic T cells specific for the protozoan Theileria parva. J. Tiss. Culture Methods 11:101-110.
14. Grange, J. M. 2001. Mycobacterium bovis infection in human beings. Tuberculosis (Edinburgh) 81:71-77.
15. Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. DeWitt, I. M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J.-P. van Vooren, M. A. Liu, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893-898.
16. Kazwala, R. R., C. J. Daborn, L. J. M. Kusiluka, S. F. H. Jiwa, J. M. Sharp, and D. M. Kambarage. 1998. Isolation of Mycobacterium species from raw milk of pastoral cattle of the southern highlands of Tanzania. Trop. Anim. Health Prod. 30:233-239.
17. Kent, S. J., A. Zhao, S. J. Best, J. D. Chandler, D. B. Boyle, and I. A. Ramshaw. 1998. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72:10180-10188.
18. Krebs, J. R. 1997. Bovine tuberculosis in cattle and badgers. London Fisheries and Food Publications, London, United Kingdom.
19. Ladel, C. H., S. Daugelat, and S. H. E. Kaufmann. 1995. Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 25:377-384.
20. Launois, P., R. DeLeys, M. N. Niang, A. Drowart, M. Adrien, P. Dierckx, J.-L. Cartel, J.-L. Sarthou, J.-P. van Vooren, and K. Huygen. 1994. T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect. Immun. 62:3679-3687.
21. + T-cell-mediated protective immunity against malaria. Proc. Natl. Acad. Sci. USA 90:5214-5218.
22. Lozes, E., K. Huygen, J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, P. Vandenbussche, J.-P. van Vooren, A. Drowart, J. B. Ulmer, and M. A. Liu. 1997. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine 15:830-833.
23. Malin A. S., K. Huygen, J. Content, M. Mackett, L. Brandt, P. Andersen, S. M. Smith, and H. M. Dockrell. 2000. Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of M tuberculosis Ag85. Microbes Infect. 2:1677-1685.
24. + T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect. Immun. 69:681-686.
25. + T cells using an ELISPOT assay. J. Immunol. Methods 181:45-54.
26. Munk, M. E., J. De Bruyn, H. Gras, and S. H. E. Kaufmann. 1994. The Mycobacterium bovis 32-kilodalton protein antigen induces human cytotoxic T-cell responses. Infect. Immun. 62:726-728.
27. Ravn, P., H. Boesen, B. K. Pedersen, and P. Andersen. 1997. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guerin. J. Immunol. 158:1949-1955.
28. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4:397-402.
29. + T cells using heterologous prime-boost immunisation strategies. Immunol. Rev. 170:29-38.
30. + T cells. Infect. Immun. 67:5223-5230.
31. + CTL specific for the mycobacterial major secreted antigen 85A. J. Immunol. 165:7088-7095.
32. Tanghe, A., S. D'Souza, V. Rosseels, O. Denis, T. H. Ottenhoff, W. Dalemans, C. Wheeler, and K. Huygen. 2001. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect. Immun. 69:3041-3047.
33. Vanderlugt, C. L., W. S. Begolka, K. L. Neville, Y. Katz-Levy, L. M. Howard, T. N. Eagar, J. A. Bluestone, and S. D. Miller. 1998. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol. Rev. 164:63-72.
34. Vordermeier, H. M., P. C. Cockle, A. Whelan, S. Rhodes, N. Palmer, D. Bakker, and R. G. Hewinson. 1999. Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle. Clin. Diagn. Lab. Immunol. 6:675-682.
35. Vordermeier, H. M., M. A. Chambers, P. J. Cockle, A. O. Whelan, J. Simmons, and R. G. Hewinson. 2002. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun. 70:3026-3032.
36. Waddington, F. G., and D. C. Ellwood. 1972. An experiment to challenge the resistance to tuberculosis in BCG vaccinated cattle in Malawi. Br. Vet. J. 128:541-552.
37. Wiker, H. G., and M. Harboe. 1992. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol. Rev. 56:648-661.